Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer

Summary

The purpose of this study is to learn whether it is better to receive the drug Metformin with standard of care for lung cancer or just standard of care.

Timeline

Start

2012-10

Primary completion

2019-05-22

Completion

2019-05-22

Outcome

Outcome not reported

Stopped (Enrollment): “Poor accrual and funding ended”

Drugs

Indications